Trials / Terminated
TerminatedNCT00430573
Efficacy of D-Cycloserine for Enhancing the Effects of CBT for Substance Use
Placebo-Controlled Evaluation of the Efficacy of D-Cycloserine for Enhancing the Effects of CBT for Substance Use
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Boston University Charles River Campus · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This study examines whether isolated doses of d-cycloserine enhance the efficacy of an exposure-based cognitive-behavioral treatment for chronic and treatment refractory substance dependence.
Detailed description
This is a placebo-controlled trial of the efficacy of 50mg d-cycloserine or matching pill placebo for enhancing the efficacy of CBT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | D-cycloserine | Single dosage of D-cycloserine is given prior to each of 6 sessions of CBT-IC treatment (sessions 5-10) |
| DRUG | Placebo | Single dosage of placebo is given prior to each of 6 sessions of CBT-IC treatment (sessions 5-10) |
Timeline
- Start date
- 2007-02-01
- Primary completion
- 2009-06-01
- Completion
- 2009-06-01
- First posted
- 2007-02-02
- Last updated
- 2018-05-17
- Results posted
- 2018-05-17
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT00430573. Inclusion in this directory is not an endorsement.